Irritable bowel syndrome
Conditions
Interventions
Experimental group:Tong-Xie Yao-fang
Control group:Place of Tong-Xie Yao-fang
Sponsors
Guangzhou University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Diagnosis of IBS-D according to ROME IV; 2. Diagnosis of diarrhea syndrome with liver stagnation and spleen deficiency according to TCM; 3. Aged 18 to 70 years; 4. Able to understand and sign a written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with inflammatory bowel disease, gastrointestinal bleeding, gastrointestinal tumors or a history of previous abdominal surgery; 2. Systemic organ diseases such as hyperthyroidism, diabetes, chronic renal impairment effect gastrointestinal motility; 3. Patients with serious primary diseases of the heart, liver, kidney, blood system or endocrine system, and patients with tumors or AIDS; 4. History of usage of other medication for IBS-D during the last week and patients taking any medication for other diseases which would impact the trial; 5. Pregnant and lactating women or women who plan to have baby; 6. Patients who are allergic to the trial medicine; 7. Patients with neurological disease, mental illness; 8. Patients who have participated in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Irritable Bowel Syndromes Symptom Severity Score ;Bristol stool form scale ; | — |
Countries
China
Contacts
Public ContactQiuke Hou
First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Outcome results
None listed